Get the Stockscreener App
79.43
1.35%
-1.09
After Hours:
76.00
-3.43
-4.32%
Genedx Holdings Corp stock is traded at $79.43, with a volume of 397.52K.
It is down -1.35% in the last 24 hours and up +35.04% over the past month.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$80.52
Open:
$82.78
24h Volume:
397.52K
Relative Volume:
0.69
Market Cap:
$2.22B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-2.2337
EPS:
-35.5597
Net Cash Flow:
$-59.99M
1W Performance:
+14.49%
1M Performance:
+35.04%
6M Performance:
+285.58%
1Y Performance:
+4,743%
1-Day Range:
$76.56
$82.78
1-Week Range:
$69.00
$82.80
52-Week Range:
$1.45
$89.11
Genedx Holdings Corp Stock (WGS) Company Profile
Name
Genedx Holdings Corp
Sector
Industry
Phone
617 780 8742
Address
333 LUDLOW STREET, STAMFORD
Compare WGS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
79.43 | 2.22B | 267.23M | -83.50M | -59.99M | -35.56 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-10-24 | Initiated | Craig Hallum | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
Genedx Holdings Corp Stock (WGS) Latest News
Algert Global LLC Buys 52,526 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Genedx CFO Kevin Feeley sells $1.65M in stock - Investing.com India
Insider Sell: Kevin Feeley Sells 22,000 Shares of GeneDx Holdings Corp (WGS) - GuruFocus.com
Genedx CFO Kevin Feeley sells $1.65M in stock By Investing.com - Investing.com UK
Connor Clark & Lunn Investment Management Ltd. Purchases Shares of 60,005 GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Principal Financial Group Inc. Buys Shares of 14,240 GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings Corp (WGS) Stock Price Up 5.52% on Oct 11 - GuruFocus.com
GeneDx Holdings Corp.'s (NASDAQ:WGS) P/S Is Still On The Mark Following 40% Share Price Bounce - Simply Wall St
7,577 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by GSA Capital Partners LLP - MarketBeat
GeneDx to Participate in Upcoming Investor Conference - Business Wire
Genedx director Ryan sells shares worth $3.3 million By Investing.com - Investing.com Canada
Genedx director Ryan sells shares worth $3.3 million - Investing.com
GeneDx Holdings Corp. (WGS) Tops Q3 Earnings and Revenue Estimates - MSN
Thompson Davis & CO. Inc. Sells 7,244 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Insider Sell Alert: Katherine Stueland Sells 45,415 Shares of Ge - GuruFocus.com
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $1,628,651.84 in Stock - MarketBeat
28,293 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Royce & Associates LP - MarketBeat
GeneDx CEO Katherine Stueland sells $3.2m in stock - Investing.com
GeneDx CEO Katherine Stueland sells $3.2m in stock By Investing.com - Investing.com UK
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover - Business Wire
GeneDx (NASDAQ:WGS) Shares Gap DownHere's What Happened - MarketBeat
GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGSWW) Sees Significant Increase in Short Interest - Defense World
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year - The Motley Fool
Chartwell Investment Partners LLC Purchases New Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings Corp (WGS) Shares Up 5.13% on Nov 12 - GuruFocus.com
Lisanti Capital Growth LLC Makes New Investment in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Achieves Profitability with Strong Q3 Growth - MSN
Brokerages Set GeneDx Holdings Corp. (NASDAQ:WGS) Price Target at $59.33 - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) Q3 2024 Earnings Call Transcript - MSN
Goldman Sachs Group Inc's Strategic Acquisition in GeneDx Holdin - GuruFocus.com
WGSGeneDx Holdings Corp. Latest Stock News & Market Updates - StockTitan
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields - Yahoo Finance
Zacks.com featured highlights include Snap, GeneDx and Leonardo - Yahoo Finance
Insider Selling: GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells 865,800 Shares of Stock - MarketBeat
3 Stocks to Buy for Stellar Earnings Acceleration in November - Yahoo Finance
Best Momentum Stocks to Buy for November 4th - Yahoo Finance
GeneDx (NASDAQ:WGS) Posts Earnings Results, Beats Estimates By $0.25 EPS - MarketBeat
GeneDx Holdings Corp (WGS) Shares Gap Down to $77.44 on Nov 1 - GuruFocus.com
US$76.67That's What Analysts Think GeneDx Holdings Corp. (NASDAQ:WGS) Is Worth After These Results - Simply Wall St
GeneDx (NASDAQ:WGS) Shares Gap Down After Insider Selling - MarketBeat
Genedx holdings CFO Kevin Feeley sells shares worth $18,248 By Investing.com - Investing.com Nigeria
Genedx holdings CFO Kevin Feeley sells shares worth $18,248 - Investing.com India
Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds (NTRA) - Seeking Alpha
GeneDx CEO Stueland sells $143,456 in company stock - Investing.com
GeneDx CEO Stueland sells $143,456 in company stock By Investing.com - Investing.com UK
Raymond James & Associates Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings: Phenomenal Gains, More Upside Potential In Medium Term (NASDAQ:WGS) - Seeking Alpha
GeneDx (NASDAQ:WGS) Price Target Raised to $70.00 at The Goldman Sachs Group - MarketBeat
Genedx Holdings Corp Stock (WGS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Genedx Holdings Corp Stock (WGS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Nov 22 '24 |
Sale |
76.07 |
9,981 |
759,242 |
22,951 |
| Ryan Jason | Director |
Nov 19 '24 |
Sale |
71.28 |
31,510 |
2,246,130 |
15,490 |
| Ryan Jason | Director |
Nov 20 '24 |
Sale |
69.13 |
15,490 |
1,070,749 |
0 |
0.88%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):